Delivery Order SPE2DB20D2014-SPE2DB24FC41S

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4,564,978,528 units of the pharmaceutical product ADVAIR HFA 230-21 MCG INHALER 12GM. The $6,435.84 firm fixed-price contract was awarded on June 21, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
The federal government has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to supply 4,565,320,989 units of the ADVAIR HFA 115-21 MCG INHALER 12GM product. The $2,206.12 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with an ultimate completion date of August 2, 2024. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,564,804,569 units of the pharmaceutical product ADVAIR HFA 230-21 MCG INHALER 12GM. The Firm Fixed Price contract, valued at $2,824.90, has a completion date of June 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,829,019 units of the pharmaceutical product ADVAIR HFA 230-21 MCG INHALER 12GM. The $4,276.83 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a performance period ending on June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM medical supplies. The $2,314.33 fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 11, 2024. The contract is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM medical supplies. The $15,998.89 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 6, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,247,368 units of the pharmaceutical product ADVAIR HFA 115-21 MCG INHALER 12GM. The $2,429.38 contract has an ultimate completion date of April 12, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp previously received an indefinite delivery contract from DLA valued up to $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,960.22 firm-fixed-price delivery order contract is for the supply of ADVAIR HFA 45-21 MCG INHALER 12GM, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,598.34 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,394.01 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,286,942 units of the pharmaceutical product ADVAIR HFA 115-21 MCG INHALER 12GM. This Firm Fixed Price contract has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award. The company holds a $999,999,999.00...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC41S
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, Corporate Office division, provides for the delivery of 4,565,096,368 units of the pharmaceutical product ADVAIR HFA 45-21 MCG INHALER 12GM. The $3,139.50 firm fixed price delivery order was awarded on July 9, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 10, 2024. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a small business set-aside designation.

Generated 10/8/24, 9:06 AM